Here are some of the existing drugs that may be repurposed to treat coronavirus Pharmaceutical companies and research facilities are looking at a variety of existing drugs as treatment options for COVID-19. Here’s a partial list. Pharmaceutical companies and research facilities are working to find new, successful treatments for those infected with the coronavirus. But clinical trials and FDA approval can take time, so while new drugs are being developed, companies are seeing if older drugs can be repurposed. Here’s a list of some of the options being explored and why they might be useful in blunting the effects of coronavirus. Actemra and other rheumatoid arthritis drugs Doctors in China have used an anti-inflammation drug to curb the effects of the coronavirus on critical patients, and now the maker of the drug says it is talking to the Food and Drug Administration about clinical trials. Tocilizumab, sold under the name Actemra and made by the Swiss pharmaceutical firm Roche, is a prescription medicine used to treat adults with moderate to severe active rheumatoid arthritis, as well as certain types of juvenile arthritis. Chinese doctors have used Tocilizumab to prevent an overreaction of the immune system that has led to organ failure and death in coronavirus patients. An initial clinical trial in China used Actemra in 20 severe COVID-19 cases. Nineteen of the patients were discharged from the hospital within two weeks and one got better, according to China’s National Health Commission. The drug has now been approved for use in China but has not yet been approved in the United States. Karsten Kleine, a spokesperson for Roche, told NBC News that the drug company “is in active discussions with the FDA, as well as government bodies and institutions around the world, to initiate clinical trials that evaluate the safety and efficacy of Actemra (tocilizumab) for the treatment of severely ill COVID-19 patients.” Roche is not alone in looking into rheumatoid arthritis drugs as a potential treatment. Sanofi and Regeneron are launching a clinical trial in New York to see if their rheumatoid arthritis drug Kevzara is effective. HIV drugs AbbVie, the creator of HIV drugs Kaletra/Aluvia, is collaborating with health authorities to determine the efficacy of using its HIV drugs to treat COVID-19. The company is working with the FDA, CDC, and European agencies to set up clinical trials of the drug. At this time, AbbVie told NBC News it cannot confirm Chinese media reports that the drug has been successful in treatment as it does not have access to Chinese clinical information. It is monitoring its current supply to make sure current HIV patients being treated by the drug will not be affected by an increase in demand. Malaria drugs Sanofi is assessing the risk and benefit of its malaria drug hydroxychloroquine for the management of coronavirus. According to the company, some health authorities are allowing the temporary use of chloroquine for the management of COVID-19, but there is insufficient data to draw any conclusions over its efficacy. Any use of the drug in this context is considered “off-label” use. Based on encouraging preliminary findings from a study in France, Sanofi is looking at ways to collaborate and partner with health authorities investigating the use of hydroxychloroquine for the management of coronavirus. Remdesivir Remdesivir is a broad spectrum anti-viral medication developed by Gilead Sciences as a treatment for Ebola and also showed success in the treatment of monkeys infected with MERs, a different type of coronavirus. It is now being tested as a potential COVID-19 treatment. Almost all these pharmacological actions of different drugs shortlisted in the COVID-19 treatment protocol globally are also shown by Curcumin found in Turmeric. China has been promoting its herbal treatment for treating symptoms of Corona. Please choose a natural response to a nature’s problem. We recommend our product Turmflu for yourself and your family and this can be ordered from our website As our contribution, we are giving away 1 Free Bottle on every order of 2 Bottles of Turmflu. Stay Safe.

Leave a Reply

Your email address will not be published.

Clinical Trial & Our Product

Since health care & medicine is an industry, formulations are controlled through intellectual property rights denying easy access to common people and maintaining the buoyancy for the interest holders. Formula’s can be patented and that covers business interests that drive innovations these days.

So instead of conducting trials on the raw root, almost all companies promote clinically tested formulations of extracts to make it appear better then how the phytochemical was in its original state. Its like extracting an important organ from the body and then putting it on support system, expecting it to perform better in insolation then how it could perform when in it was in its natural form. The truth is, that the best way to consume a plant based medicine is in its raw form. Curcumin is one of the active ingredients in the root Curcuma Longa.

Since its more important to know what your food ate then what you ate, its important to know that the supplements you are using based on curcumin has curcumin from a gene modified variety of curcuma longa which suffers from an imbalance of every other mineral. You see a plant also behaves how a human body behaves when it is injected with steroids to gain muscle mass for body building purpose. The plants have higher levels of curcumin but all other secondary minerals found along curcumin in the plant get compromised as the plant can not feed all nutritions equally when it is designed to feed most of its nutrition towards developing higher levels of curcumin. It has severe side effects on the health of the plant and apparently on the people consuming such plants or extracts coming from these plants. However marketing and promotions have evolved to divert attention very wisely.

An extract of any herb can never be stored in its original state and hence needs base agents, preservatives which hardly leave it how it must be. We believe that access to medicine and healthcare is a basic right of every human and animal living on planet earth. Hence we do not first extract and then add preservatives or agents like pepperine to make the extract bio-available. This is the reason we never patent any of our products. We instead hand process the whole root we cultivate in our farms and share it with the people under different brand names for different health conditions based on the concentration of minerals present at testing. You can also buy the seed from us and cultivate it but it will certainly not be as potent as you get from us.

How potent is the active ingredient in the plant depends on the quality of seed, soil, water and environment. Our products work far better then most of the curcumin based supplements globally being used for Therapeutic benefits.

We do not intend to formulate or patent our products. So instead of choosing a supplement with an extract, choose wisely and go for the best and not the Cheapest.

All our products are cultivated, harvested, hand processed and distributed directly from our own farms to ensure that people who depend on our products for their acute and chronic problems get consistent supply of highest quality, ultra premium, medicinal grade, Non-GMO, Indigenous, Naturally enriched with curcumin, Wild Strand curcuma longa powder for therapeutic benefits. We cultivate this in the middle of a national park which happens to be the best breeding ground for Bengal tigers in India called Bandhavgarh.